跳至主要内容
临床试验/NL-OMON23669
NL-OMON23669尚未招募不适用

The efficacy of clarithromycin plus adalimumab versus clarithromycin plus placebo adalimumab for the treatment of Hidradenitis Suppurativa.

Erasmus medical center Rotterdam0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
30

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • Male/female patients older than 18 years of age with active moderate to severe hidradenitis suppurativa (Hurley stage 2 or Hurley stage 3).

排除标准

  • 1. Subject has been treated with systemic corticosteroids (oral or parenteral) less than 4 weeks prior to baseline. Inhaled corticosteroids for stable medical conditions are allowed;
  • 2. Subject has a poorly controlled medical condition, such as uncontrolled diabetes, unstable heart disease, recent cerebrovascular accidents, and any other condition, which in the opinion of the investigator, would put the subject at risk by participation in the study;

研究者

发起方
Erasmus medical center Rotterdam

相似试验

Adalimumab for the treatment of hs. | 临床试验